GlassScriptPhysician profile
Tracy Lee Aigner
NPI 1235232414
$517.56
in general payments reported to CMS, 2019-2025
12 companies · $84.95 in 2025
The $84.95 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $19.62 · 2021: $91.01 · 2022: $55.66 · 2023: $117 · 2024: $42.17 · 2025: $84.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $126.46 | 2021-2025 | Eysuvis, Precision 1 |
| Bausch & Lomb Americas INC. | $90.24 | 2023-2025 | Infuse, Vyzulta, Miebo |
| Novartis Pharmaceuticals Corporation | $68.36 | 2020-2023 | |
| Johnson & Johnson Vision Care, INC. | $52.75 | 2019-2025 | |
| Eyevance Pharmaceuticals LLC | $39.55 | 2019 | |
| Oyster Point Pharma, INC. | $31.90 | 2022-2023 | Tyrvaya |
| Dompe US, INC. | $20.60 | 2022 | |
| Kala Pharmaceuticals, INC. | $20.40 | 2021 | |
| Allergan, INC. | $20.20 | 2021 | |
| Coopervision INC. | $20.10 | 2019 | |
| Abb Con-Cise Optical Group LLC | $13.53 | 2019 | |
| Abbvie INC. | $13.47 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Aigner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.